Biomerica, Inc.
BMRA
$2.80
$0.041.45%
NASDAQ
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -1.88% | 5.05% | 1.40% | 1.72% | 1.41% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.88% | 5.05% | 1.40% | 1.72% | 1.41% |
| Cost of Revenue | 0.10% | 2.61% | 7.93% | 11.58% | -1.78% |
| Gross Profit | -17.60% | 23.99% | -32.62% | -46.88% | 36.32% |
| SG&A Expenses | -15.88% | -15.25% | -4.38% | 1.23% | -9.88% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.33% | -10.79% | -3.05% | 1.80% | -6.21% |
| Operating Income | 19.36% | 23.62% | 6.92% | -1.86% | 11.84% |
| Income Before Tax | 16.26% | 23.09% | 6.81% | -0.18% | 16.26% |
| Income Tax Expenses | -95.24% | -91.67% | -84.81% | -68.06% | -17.65% |
| Earnings from Continuing Operations | 16.81% | 23.61% | 7.83% | 0.61% | 16.27% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.81% | 23.61% | 7.83% | 0.61% | 16.27% |
| EBIT | 19.36% | 23.62% | 6.92% | -1.86% | 11.84% |
| EBITDA | 19.71% | 24.03% | 7.17% | -1.81% | 11.93% |
| EPS Basic | 20.69% | 26.44% | 14.23% | 12.49% | 30.25% |
| Normalized Basic EPS | 20.16% | 25.95% | 13.25% | 11.80% | 30.25% |
| EPS Diluted | 18.71% | 25.23% | 13.15% | 12.39% | 29.77% |
| Normalized Diluted EPS | 20.16% | 25.95% | 13.25% | 11.80% | 30.25% |
| Average Basic Shares Outstanding | 5.18% | 4.33% | 6.09% | 11.51% | 18.84% |
| Average Diluted Shares Outstanding | 5.18% | 4.33% | 6.09% | 11.51% | 18.84% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |